Multicenter Analysis of Treatment Outcomes for Systemic Therapy in Well Differentiated Grade 3 Neuroendocrine Tumors (NET G3)

SIMPLE SUMMARY: Neuroendocrine tumors grade 3 (NET G3) are a newly defined subgroup of neuroendocrine neoplasms. They do not respond well to platinum + etoposide-based chemotherapy. The alternative suggested options have not been analyzed in untreated NET G3 patients so far, therefore the optimal tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Apostolidis, Leonidas, Dal Buono, Arianna, Merola, Elettra, Jann, Henning, Jäger, Dirk, Wiedenmann, Bertram, Winkler, Eva Caroline, Pavel, Marianne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073753/
https://www.ncbi.nlm.nih.gov/pubmed/33923759
http://dx.doi.org/10.3390/cancers13081936

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073753/
https://www.ncbi.nlm.nih.gov/pubmed/33923759
http://dx.doi.org/10.3390/cancers13081936

Ejemplares similares